Caveness Michelle H 4

What Happened Michelle H. Caveness, Senior Vice President & Chief Manufacturing Officer of Eastman Chemical Co. (EMN), received equity awards on February 24, 2026: 33,223 derivative awards (stock options) and 4,571 restricted stock units (RSUs). Both grants are reported at a $0 acquisition price on the Form 4, indicating compensation awards rather than open-market purchases or sales. No shares were sold or exercised in this filing.

Key Details

• Transaction date: 2026-02-24; Form 4 filed: 2026-02-26 (appears timely).
• Awards: 33,223 option-like derivative awards and 4,571 restricted stock units (total 37,794 awards).
• Prices: reported $0.00 acquisition price (typical for grants/awards).
• Vesting/exercise terms:
  • Footnote F1: One-third of the options become exercisable on Feb 24 of 2027, 2028, and 2029, respectively.
  • Footnotes F2–F3: Each RSU equals a contingent right to one share; RSUs vest and will be paid out in unrestricted shares on Feb 24, 2029, subject to continued employment.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Transaction code: "A" = Award/Grant (derivative awards); no 10b5-1 plan, tax withholding, or late-filing indication noted.

Context These grants are standard long-term incentive awards meant to align executive payout with company performance and retention. Options here are not exercised (they are newly granted and will vest over time); RSUs are contingent and vest on the third anniversary only if employment continues. Such awards are routine compensation actions and do not by themselves indicate buying or selling sentiment in the open market.